TherapeuticsMD reported $40.13M in Assets for its fiscal quarter ending in June of 2024.





Assets Change Date
AbbVie USD 147.68B 12.57B Sep/2026
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Cipla INR 434.34B 9.38B Sep/2026
Clal Biotechnology ILS 158.39M 24.3M Dec/2023
Compugen USD 138.36M 7.5M Jun/2026
CSL USD 37.9B 1.5B Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Novo Nordisk DKK 90.92B 468.3B Jun/2026
Pfizer USD 204.54B 3.41B Sep/2026
TherapeuticsMD USD 40.13M 1.96M Jun/2024